Bowel cancer drug that ‘shrunk 60% of tumours in incredibly exciting trial’ is hailed a ‘game-changer’ ...Middle East

The U.S. Sun - News
Bowel cancer drug that ‘shrunk 60% of tumours in incredibly exciting trial’ is hailed a ‘game-changer’
A COMBINATION of two immunotherapy drugs could be used to treat the most common form of bowel cancer, scientists say. “Incredibly exciting” trials showed tumours had shrunk or remained stable in three out of five patients. Getty - ContributorScientists have hailed a ‘game-changing’ new combination of immunotherapy drugs to treat bowel cancer[/caption] Botensilimab and balstilimab could “offer new hope” for those diagnosed with a type of cancer that has previously not responded to immunotherapy, researchers from Anglia Ruskin University said. Both drugs work by triggering the body’s immune system to attack cancer cells. Describing the treatment as “potentially game changing”,

Hence then, the article about bowel cancer drug that shrunk 60 of tumours in incredibly exciting trial is hailed a game changer was published today ( ) and is available on The U.S. Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bowel cancer drug that ‘shrunk 60% of tumours in incredibly exciting trial’ is hailed a ‘game-changer’ )

Apple Storegoogle play

Last updated :

Also on site :